FC
TEVA icon

FORA Capital’s Teva Pharmaceuticals TEVA Stock Holding History

FORA Capital’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-49,372
Closed -$1.49M – 545
2026
Q1 		$1.49M Buy
49,372
+4,946
+11% +$159K 0.11% 186
2025
Q4 		$1.39M Buy
+44,426
New +$1.09M 0.17% 150
2025
Q1 		– Sell
-106,078
Closed -$2.34M – 643
2024
Q4 		$2.34M Buy
+106,078
New +$1.93M 0.27% 111
2022
Q2 		– Sell
-23,643
Closed -$222K – 678
2022
Q1 		$222K Buy
+23,643
New +$197K 0.04% 466
2020
Q2 		– Sell
-125,001
Closed -$1.12M – 1299
2020
Q1 		$1.12M Buy
+125,001
New +$1.28M 0.24% 105

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

FORA Capital's TEVA Position: Q2 2026 in Review

FORA Capital sold out of Teva Pharmaceuticals (TEVA) in Q2 2026, closing a stake of 49,372 shares — an estimated $1.49M sold.

FORA Capital first reported a position in TEVA in Q1 2020 and held it in 5 quarters. The position peaked at $2.34M in Q4 2024. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • FORA Capital reported no remaining Teva Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • FORA Capital sold 49,372 Teva Pharmaceuticals shares in Q2 2026, an estimated $1.49M.
  • FORA Capital first reported a position in Teva Pharmaceuticals in Q1 2020 and held it in 5 quarters.
  • FORA Capital's Teva Pharmaceuticals position peaked at $2.34M in Q4 2024.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on FORA Capital's 13F filing for Q2 2026, filed 13 Aug 2026.